UE LifeSciences
Growth Stage
FemTech company
Overview
Raised: $480,308
Platform
Self Managed
Start Date
11/10/2021
Close Date
02/28/2022
Min. Goal
$5,000
Max. Goal
$5,000,000
Min. Investment
$5,000
Security Type
Equity - Common
SEC Filing Type
RegD 506(c)
Price Per Share
$5.00
Pre-Money Valuation
$50,000,000
Status
Funded
Reporting Date
02/27/2022
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$4,407
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2003
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
Philadelphia, Pennsylvania
UE LifeSciences, with a valuation of $50 million, is raising funds independently through Reg D 506(c) crowdfunding. The company has developed non-invasive and radiation-free devices and apps for the detection of breast and cervical cancer. The technology of UE LifeSciences is US FDA cleared, CE marked, and clinically validated by multiple independent studies. UE LifeSciences has successfully pre-screened over 450,000 women and has been featured in the New York Times, Forbes, BBC, and Vogue. Mihir Shah and Matthew Campisi founded UE LifeSciences in 2003. The current crowdfunding campaign has a minimum target of $5,000 and a maximum target of $5,000,000. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.